CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities attributable to continuing operations:
Net earnings	$ 276,554	$ 221,609	$ 566,527
Add back: (earnings) loss from discontinued operations, net of tax	(509)	366,070	(49,187)
Net earnings from continuing operations	276,045	587,679	517,340
Adjustments to reconcile net earnings from continuing operations to net cash provided by operating activities attributable to continuing operations:
Stock-based compensation expense	146,816	102,268	89,724
Depreciation	41,402	41,271	34,355
Amortization of intangibles	28,559	7,525	8,727
Deferred income taxes	(57,969)	15,384	(12,753)
Other adjustments, net	27,690	27,281	13,561
Changes in assets and liabilities
Accounts receivable	(34,021)	(24,213)	(17,861)
Other assets	1,743	(33,224)	(24,162)
Accounts payable and other liabilities	458,757	24,155	33,741
Income taxes payable and receivable	(2,854)	16,913	(4,161)
Deferred revenue	26,331	23,513	9,478
Net cash provided by operating activities attributable to continuing operations	912,499	788,552	647,989
Cash flows from investing activities attributable to continuing operations:
Acquisitions, net of cash	(859,905)	0	(3,759)
Capital expenditures	(79,971)	(42,376)	(39,035)
Purchases of investments	0	(9,115)	0
Net cash distribution related to Separation of IAC	0	(3,870,550)	0
Other, net	51	(90)	1,064
Net cash used in investing activities attributable to continuing operations	(939,825)	(3,922,131)	(41,730)
Cash flows from financing activities attributable to continuing operations:
Borrowings under the Credit Facility	0	20,000	40,000
Proceeds from Senior Notes offerings	500,000	1,000,000	350,000
Proceeds from Exchangeable Senior Notes offerings	0	0	1,150,000
Principal payment on Senior Notes	0	(400,000)	0
Principal payments on Credit Facility	0	(20,000)	(300,000)
Payments to settle exchangeable notes	(630,658)	0	0
Purchase of exchangeable note hedges	0	0	(303,428)
Proceeds from issuance of warrants	0	0	166,520
Proceeds from the settlement of exchangeable note hedges	1,089,592	0	0
Payments to settle warrants related to exchangeable notes	(882,187)	0	0
Debt issuance costs	(7,124)	(13,517)	(27,815)
Purchase of Former Match Group treasury stock	0	(132,868)	(216,353)
Proceeds from stock offering	0	1,421,801	0
Proceeds from issuance of common stock pursuant to stock-based awards	58,424	155,402	0
Withholding taxes paid on behalf of employees on net settled stock-based awards	(15,726)	(211,958)	(203,177)
Purchase of noncontrolling interests	(1,473)	(15,827)	(1,650)
Other, net	258	(15,187)	(73)
Net cash provided by financing activities attributable to continuing operations	111,106	1,787,846	654,024
Total cash provided by (used in) continuing operations	83,780	(1,345,733)	1,260,283
Net cash provided by operating activities attributable to discontinued operations	0	13,630	289,949
Net cash used in investing activities attributable to discontinued operations	0	(963,420)	(287,798)
Net cash used in financing activities attributable to discontinued operations	0	(110,959)	(254,193)
Total cash used in discontinued operations	0	(1,060,749)	(252,042)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(7,570)	5,426	(1,568)
Net increase (decrease) in cash, cash equivalents, and restricted cash	76,210	(2,401,056)	1,006,673
Cash, cash equivalents, and restricted cash at beginning of period	739,302	3,140,358	2,133,685
Cash, cash equivalents, and restricted cash at end of period	$ 815,512	$ 739,302	$ 3,140,358